These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Nomifensine-induced immune hemolytic anemia and posttransfusion purpura in the same patient. Mueller-Eckhardt C; Allolio B; Salama A; Kiefel V; Deuss U Transfusion; 1987; 27(3):250-2. PubMed ID: 3590288 [TBL] [Abstract][Full Text] [Related]
17. Nomifensine withdrawn by manufacturer. FDA Drug Bull; 1986 Jun; 16(1):7-8. PubMed ID: 3732683 [No Abstract] [Full Text] [Related]
18. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. Salama A; Mueller-Eckhardt C N Engl J Med; 1985 Aug; 313(8):469-74. PubMed ID: 4022080 [TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex markers in patients with nomifensine-induced immune hemolytic anemia. Mueller-Eckhardt G; Giers G; Salama A; Schendel DJ; Fass G; Mueller-Eckhardt C Vox Sang; 1988; 54(1):59-61. PubMed ID: 3348023 [TBL] [Abstract][Full Text] [Related]
20. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis. Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477 [No Abstract] [Full Text] [Related] [Next] [New Search]